Catherine Hewison

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Comparative effectiveness of three linezolid management strategies for peripheral neuropathy during multidrug- or rifampicin-resistant tuberculosis treatment.

Comparative effectiveness of three linezolid management strategies for peripheral neuropathy during multidrug- or rifampicin-resistant tuberculosis treatment.

Journal: medRxiv : the preprint server for health sciences

Published: March 27, 2026

Comparison of three linezolid management strategies for peripheral neuropathy in multidrug- or rifampicin-resistant tuberculosis treatment: a target trial emulation.

Comparison of three linezolid management strategies for peripheral neuropathy in multidrug- or rifampicin-resistant tuberculosis treatment: a target trial emulation.

Journal: medRxiv : the preprint server for health sciences

Published: March 27, 2026

Comparison of three linezolid management strategies for peripheral neuropathy in multidrug- or rifampicin-resistant tuberculosis treatment: a target trial emulation.

Comparison of three linezolid management strategies for peripheral neuropathy in multidrug- or rifampicin-resistant tuberculosis treatment: a target trial emulation.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: March 15, 2026

Using causal frameworks to reduce bias in observational TB research: a comparison of model-building approaches.

Using causal frameworks to reduce bias in observational TB research: a comparison of model-building approaches.

Journal: IJTLD open

Published: February 05, 2026

Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherence.

Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherence.

Journal: American journal of epidemiology

Published: October 08, 2025

Characterizing Treatment Adherence Trajectories in the endTB Multisite Cohort of Drug-Resistant Tuberculosis Patients: An Application of Group-Based Trajectory Modeling.

Characterizing Treatment Adherence Trajectories in the endTB Multisite Cohort of Drug-Resistant Tuberculosis Patients: An Application of Group-Based Trajectory Modeling.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: May 29, 2025

Characterizing treatment adherence trajectories in the endTB multisite cohort of drug-resistant tuberculosis patients: an application of group-based trajectory modelling.

Characterizing treatment adherence trajectories in the endTB multisite cohort of drug-resistant tuberculosis patients: an application of group-based trajectory modelling.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: May 29, 2025

Phenotypic and genotypic resistance to bedaquiline in patients with multi-drug-resistant tuberculosis-experiences from Armenia.

Phenotypic and genotypic resistance to bedaquiline in patients with multi-drug-resistant tuberculosis-experiences from Armenia.

Journal: Antimicrobial agents and chemotherapy

Published: April 09, 2025

Scanned: The global investments in computer-aided detection and ultraportable X-ray for tuberculosis.

Scanned: The global investments in computer-aided detection and ultraportable X-ray for tuberculosis.

Journal: PLOS global public health

Published: March 17, 2025

Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy.

Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy.

Journal: IJTLD open

Published: February 28, 2025

Effectiveness of a bedaquiline, linezolid, clofazimine 'core' for multidrug-resistant TB.

Effectiveness of a bedaquiline, linezolid, clofazimine 'core' for multidrug-resistant TB.

Journal: IJTLD open

Published: October 02, 2024

The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country Multidrug-Resistant/Rifampicin-Resistant Tuberculosis Cohort.

The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country Multidrug-Resistant/Rifampicin-Resistant Tuberculosis Cohort.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 26, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026